Strategic Partnerships Brain+ is actively forming collaborations with care home groups, UK-based organizations, and European academic institutions, indicating a strong market expansion trajectory that could lead to increased deployment opportunities across healthcare and social care sectors.

Market Focus The company is concentrating on the UK and German markets, demonstrating potential for tailored product offerings and localization services to meet the specific needs of European dementia care providers.

Product Development With ongoing development of CST-Assistant and clinical validation through studies like those with Age UK and Gothenburg University, Brain+ is building a robust evidence base, which can be leveraged to boost sales through evidence-driven marketing and strategic tendering.

Funding & Opportunities With recent funding of 1.5 million USD and low revenue levels, there is potential for partners or investors to engage in co-development, licensing, and distribution, especially in expanding digital dementia care solutions.

Digital Health Focus The company’s emphasis on scalable, innovative digital cognitive therapy positions it well to attract healthcare providers looking to integrate non-drug, technology-based solutions into dementia treatment and care plans.